Skip to content

Nepafenac

Save $3,232/mo
53× cheaper

ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ).

United States
$3,294
per month
India
$63
per month
You save
$3,232
98% cheaper in India
40.8K US scripts/yr$131.7M potential annual savings$134.3M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC15H14N2O2

SMILES: C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N

Compare the price
US price$3,294per month
India price$63per month
You save$3,23298% less

Based on 30 units per month. US $109.81 vs India $2.09 per unit.

Total over 1 periodSave $3,232$3,294$63
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$19,391
Estimated travel cost
− $2,300
Net savings after travel
$17,091

Even after travel, you could come out ahead by about $17,091.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Nepafenac is filled about 40.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$134.3M
If sourced from India
$2.6M
Potential annual savings
$131.7M
98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.